NFKBIE


Description

The NFKBIE (NFKB inhibitor epsilon) is a protein-coding gene located on chromosome 6.

NFKBIE, also known as NFKBIE, is a protein that plays a role in regulating NF-κB activity. It is produced in greater amounts following NF-κB activation and during the development of certain immune cells (myelopoiesis). NFKBIE functions by physically retaining NF-κB in the cytoplasm, preventing it from entering the nucleus and activating gene expression. This inhibition is achieved through the interaction of NFKBIE with NF-κB subunits such as REL, RELA, and RELB. The NF-κB complex itself is comprised of various proteins like NFKB1 or NFKB2, which associate with REL, RELA, or RELB. The activity of NF-κB is normally controlled by other proteins called I-kappa-B proteins (like NFKBIA or NFKBIB), which bind to NF-κB and hold it in the cytoplasm. Phosphorylation of these I-kappa-B proteins by kinases (IKBKA, or IKBKB) triggers their breakdown, allowing NF-κB to become active and move to the nucleus. Once in the nucleus, the activated NF-κB binds to specific DNA sequences called kappa-B-binding motifs, which are required to initiate gene expression. This activation can also involve interactions with other transcription factors, such as STAT (e.g., STAT6), AP-1 (JUN), and NFAT (e.g., NFATC1).

NFKBIE inhibits NF-κB by binding to and retaining it in the cytoplasm, preventing its translocation to the nucleus and subsequent DNA binding. Specifically, it blocks the DNA-binding activity of the NF-κB p50-p65 and p50-c-Rel complexes.

NFKBIE is also known as IKBE.

Associated Diseases



Disclaimer

The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.